Table 2

Target Artery Sheath Sizes, Closure Devices, and ACT Values

Bivalirudin (n = 125)UFH (n = 111)p Value
Artery
 Subclavian1 (0.8%)4 (3.6%)0.2993
 Renal17 (13.6%)16 (14.4%)0.9928
 Iliacs41 (32.8%)34 (30.6%)0.8282
 Femoral9 (7.2%)8 (7.2%)0.8034
 Profunda2 (1.6%)2 (1.8%)0.6995
 SFA65 (52.0%)45 (40.5%)0.1029
 Popliteal19 (15.2%)9 (8.1%)0.1389
 Below the knee14 (11.2%)18 (16.2%)0.3503
 Celiac0 (0.8%)1 (0.9%)0.5300
 SMA2 (1.6%)1 (0.9%)0.9180
Sheath sizes used
 5-F8 (6.4%)8 (7.2%)0.9904
 6-F65 (52.0%)73 (65.8%)0.0444
 7-F43 (34.4%)24 (21.6%)0.0425
 8-F9 (7.2%)6 (5.4%)0.7680
Closure devices used11 (8.8%)5 (4.5%)0.2928
ACT values
 5 min328 ± 68.7236 ± 61.4<0.001
 30 min325 ± 67.6223 ± 56.4<0.001

ACT = activated clotting time; SFA = superficial femoral artery; SMA = superior mesenteric artery; UFH = unfractionated heparin.